Please use this identifier to cite or link to this item:
Title: Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Austin Authors: Williams, Michael;Perera, Marlon ;Nouhaud, François Xavier;Coughlin, Geoffrey
Affiliation: Surgery (University of Melbourne)
Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Department of Surgery, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
Issue Date: Jan-2021
Publication information: Investigative and Clinical Urology 2021-01; 62(1): 111-120
Abstract: To describe the surgical technique and examine the feasibility and outcomes following robotic pelvic exenteration and extended pelvic resection for rectal and/or urological malignancy. We present a case series of seven patients with locally advanced or synchronous urological and/or rectal malignancy who underwent robotic total or posterior pelvic exenteration between 2012-2016. In total, we included seven patients undergoing pelvic exenteration or extended pelvic resection. The mean operative time was 485±157 minutes and median length of stay was 9 days (6-34 days). There was only one Clavien-Dindo complication grade 3 which was a vesicourethral anastomotic leak requiring rigid cystoscopy and bilateral ureteric catheter insertion. Eighty-five percent of patients had clear colorectal margins with a median margin of 3.5 mm (0.7-8.0 mm) while all urological margins were clear. Six out of seven patients had complete (grade 3) total mesorectal excision. Three patients experienced recurrence at a median of 22 months (21-24 months) post-operatively. Of the three recurrences, one was systemic only whilst two were both local and systemic. One patient died from complications of dual rectal and prostate cancer 31 months after the surgery. We report a large series examining robotic pelvic exenteration or extended pelvic resection and describe the surgical technique involved. The robotic approach to pelvic exenteration is highly feasible and demonstrates acceptable peri-operative and oncological outcomes. It has the potential to benefit patients undergoing this highly complex and morbid procedure.
DOI: 10.4111/icu.20200176
ORCID: 0000-0002-3389-3875
PubMed URL: 33381928
Type: Journal Article
Subjects: Colorectal cancer
Minimally invasive surgical procedures
Pelvic exenteration
Prostate cancer
Appears in Collections:Journal articles

Files in This Item:
1 files
File SizeFormat 
25535.pdf4.39 MBAdobe PDF
Download Adobe
Show full item record

Page view(s)

checked on May 15, 2021


checked on May 15, 2021

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.